看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 10.5x - 11.6x | 11.1x |
| Selected Fwd EBITDA Multiple | 5.5x - 6.1x | 5.8x |
| Fair Value | €13.36 - €14.51 | €13.94 |
| Upside | 17.4% - 27.5% | 22.5% |
| Benchmarks | Ticker | Full Ticker |
| Paul Hartmann AG | PHH2 | DB:PHH2 |
| Eckert & Ziegler SE | EUZ | DB:EUZ |
| Medacta Group SA | MOVE | SWX:MOVE |
| Svas Biosana S.p.A. | SVS | BIT:SVS |
| Geratherm Medical AG | GME | DB:GME |
| Ion Beam Applications SA | IOB | DB:IOB |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| PHH2 | EUZ | MOVE | SVS | GME | IOB | ||
| DB:PHH2 | DB:EUZ | SWX:MOVE | BIT:SVS | DB:GME | DB:IOB | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | -0.1% | 13.6% | 16.4% | 2.6% | NM- | 43.1% | |
| 3Y CAGR | -6.6% | 24.9% | 13.3% | 12.4% | NM- | 22.7% | |
| Latest Twelve Months | 110.2% | 22.8% | 18.8% | 7.6% | -163.9% | 181.8% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 7.3% | 23.5% | 24.6% | 11.6% | 10.3% | 5.8% | |
| Prior Fiscal Year | 3.4% | 23.2% | 23.4% | 11.2% | 17.5% | 2.4% | |
| Latest Fiscal Year | 7.1% | 26.2% | 24.1% | 12.0% | -16.7% | 6.4% | |
| Latest Twelve Months | 7.1% | 27.3% | 24.1% | 12.0% | -16.7% | 6.4% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 0.44x | NA | 5.63x | 0.59x | 0.66x | 0.53x | |
| EV / LTM EBITDA | 6.2x | NA | 23.4x | 4.9x | -3.9x | 8.3x | |
| EV / LTM EBIT | 9.7x | NA | 35.8x | 7.3x | -2.2x | 9.4x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | -3.9x | 5.5x | 23.4x | ||||
| Historical EV / LTM EBITDA | -387.5x | 9.4x | 18.0x | ||||
| Selected EV / LTM EBITDA | 10.5x | 11.1x | 11.6x | ||||
| (x) LTM EBITDA | 32 | 32 | 32 | ||||
| (=) Implied Enterprise Value | 333 | 350 | 368 | ||||
| (-) Non-shareholder Claims * | 69 | 69 | 69 | ||||
| (=) Equity Value | 402 | 420 | 437 | ||||
| (/) Shares Outstanding | 29.3 | 29.3 | 29.3 | ||||
| Implied Value Range | 13.74 | 14.34 | 14.94 | ||||
| FX Rate: EUR/EUR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 13.74 | 14.34 | 14.94 | 11.38 | |||
| Upside / (Downside) | 20.8% | 26.0% | 31.3% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | PHH2 | EUZ | MOVE | SVS | GME | IOB | |
| Enterprise Value | 1,051 | 3,644 | 3,328 | 72 | 9 | 264 | |
| (+) Cash & Short Term Investments | 161 | 112 | 32 | 37 | 10 | 73 | |
| (+) Investments & Other | 7 | 16 | 0 | 0 | 1 | 40 | |
| (-) Debt | (294) | (49) | (244) | (66) | (3) | (44) | |
| (-) Other Liabilities | (48) | (1) | 0 | (0) | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 877 | 3,722 | 3,116 | 43 | 17 | 333 | |
| (/) Shares Outstanding | 3.6 | 63.2 | 19.9 | 5.3 | 5.4 | 29.3 | |
| Implied Stock Price | 247.00 | 58.90 | 156.43 | 8.16 | 3.05 | 11.38 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.06 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 247.00 | 58.90 | 147.20 | 8.16 | 3.05 | 11.38 | |
| Trading Currency | EUR | EUR | CHF | EUR | EUR | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.06 | 1.00 | 1.00 | 1.00 | |